Report Detail

Chemical & Material COVID-19 Impact on Global API(Active Pharmaceutical Ingredient) Intermediate, Market Insights and Forecast to 2026

  • RnM4085082
  • |
  • 30 June, 2020
  • |
  • Global
  • |
  • 114 Pages
  • |
  • QYResearch
  • |
  • Chemical & Material

1 Study Coverage

  • 1.1 API(Active Pharmaceutical Ingredient) Intermediate Product Introduction
  • 1.2 Market Segments
  • 1.3 Key API(Active Pharmaceutical Ingredient) Intermediate Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global API(Active Pharmaceutical Ingredient) Intermediate Market Size Growth Rate by Type
    • 1.4.2 Type I
    • 1.4.3 Type II
  • 1.5 Market by Application
    • 1.5.1 Global API(Active Pharmaceutical Ingredient) Intermediate Market Size Growth Rate by Application
    • 1.5.2 Oncology
    • 1.5.3 Diabetes
    • 1.5.4 Endocrinology
    • 1.5.5 Cardiovascular Disease
    • 1.5.6 CNS & Neurological Disorders
  • 1.6 Coronavirus Disease 2019 (Covid-19): API(Active Pharmaceutical Ingredient) Intermediate Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the API(Active Pharmaceutical Ingredient) Intermediate Industry
      • 1.6.1.1 API(Active Pharmaceutical Ingredient) Intermediate Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and API(Active Pharmaceutical Ingredient) Intermediate Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for API(Active Pharmaceutical Ingredient) Intermediate Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global API(Active Pharmaceutical Ingredient) Intermediate Market Size Estimates and Forecasts
    • 2.1.1 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue 2015-2026
    • 2.1.2 Global API(Active Pharmaceutical Ingredient) Intermediate Sales 2015-2026
  • 2.2 API(Active Pharmaceutical Ingredient) Intermediate Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global API(Active Pharmaceutical Ingredient) Intermediate Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global API(Active Pharmaceutical Ingredient) Intermediate Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global API(Active Pharmaceutical Ingredient) Intermediate Competitor Landscape by Players

  • 3.1 API(Active Pharmaceutical Ingredient) Intermediate Sales by Manufacturers
    • 3.1.1 API(Active Pharmaceutical Ingredient) Intermediate Sales by Manufacturers (2015-2020)
    • 3.1.2 API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Manufacturers (2015-2020)
  • 3.2 API(Active Pharmaceutical Ingredient) Intermediate Revenue by Manufacturers
    • 3.2.1 API(Active Pharmaceutical Ingredient) Intermediate Revenue by Manufacturers (2015-2020)
    • 3.2.2 API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global API(Active Pharmaceutical Ingredient) Intermediate Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by API(Active Pharmaceutical Ingredient) Intermediate Revenue in 2019
    • 3.2.5 Global API(Active Pharmaceutical Ingredient) Intermediate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 API(Active Pharmaceutical Ingredient) Intermediate Price by Manufacturers
  • 3.4 API(Active Pharmaceutical Ingredient) Intermediate Manufacturing Base Distribution, Product Types
    • 3.4.1 API(Active Pharmaceutical Ingredient) Intermediate Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers API(Active Pharmaceutical Ingredient) Intermediate Product Type
    • 3.4.3 Date of International Manufacturers Enter into API(Active Pharmaceutical Ingredient) Intermediate Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global API(Active Pharmaceutical Ingredient) Intermediate Market Size by Type (2015-2020)
    • 4.1.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales by Type (2015-2020)
    • 4.1.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue by Type (2015-2020)
    • 4.1.3 API(Active Pharmaceutical Ingredient) Intermediate Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global API(Active Pharmaceutical Ingredient) Intermediate Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Forecast by Type (2021-2026)
    • 4.2.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast by Type (2021-2026)
    • 4.2.3 API(Active Pharmaceutical Ingredient) Intermediate Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global API(Active Pharmaceutical Ingredient) Intermediate Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global API(Active Pharmaceutical Ingredient) Intermediate Market Size by Application (2015-2020)
    • 5.1.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales by Application (2015-2020)
    • 5.1.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue by Application (2015-2020)
    • 5.1.3 API(Active Pharmaceutical Ingredient) Intermediate Price by Application (2015-2020)
  • 5.2 API(Active Pharmaceutical Ingredient) Intermediate Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Forecast by Application (2021-2026)
    • 5.2.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global API(Active Pharmaceutical Ingredient) Intermediate Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America API(Active Pharmaceutical Ingredient) Intermediate by Country
    • 6.1.1 North America API(Active Pharmaceutical Ingredient) Intermediate Sales by Country
    • 6.1.2 North America API(Active Pharmaceutical Ingredient) Intermediate Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America API(Active Pharmaceutical Ingredient) Intermediate Market Facts & Figures by Type
  • 6.3 North America API(Active Pharmaceutical Ingredient) Intermediate Market Facts & Figures by Application

7 Europe

  • 7.1 Europe API(Active Pharmaceutical Ingredient) Intermediate by Country
    • 7.1.1 Europe API(Active Pharmaceutical Ingredient) Intermediate Sales by Country
    • 7.1.2 Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe API(Active Pharmaceutical Ingredient) Intermediate Market Facts & Figures by Type
  • 7.3 Europe API(Active Pharmaceutical Ingredient) Intermediate Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate by Region
    • 8.1.1 Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Sales by Region
    • 8.1.2 Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Market Facts & Figures by Type
  • 8.3 Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America API(Active Pharmaceutical Ingredient) Intermediate by Country
    • 9.1.1 Latin America API(Active Pharmaceutical Ingredient) Intermediate Sales by Country
    • 9.1.2 Latin America API(Active Pharmaceutical Ingredient) Intermediate Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America API(Active Pharmaceutical Ingredient) Intermediate Market Facts & Figures by Type
  • 9.3 Central & South America API(Active Pharmaceutical Ingredient) Intermediate Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate by Country
    • 10.1.1 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Sales by Country
    • 10.1.2 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Market Facts & Figures by Type
  • 10.3 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Jigs Chemical
    • 11.1.1 Jigs Chemical Corporation Information
    • 11.1.2 Jigs Chemical Description, Business Overview and Total Revenue
    • 11.1.3 Jigs Chemical Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Products Offered
    • 11.1.5 Jigs Chemical Recent Development
  • 11.2 Sanofi Winthrop Industrie S.A.
    • 11.2.1 Sanofi Winthrop Industrie S.A. Corporation Information
    • 11.2.2 Sanofi Winthrop Industrie S.A. Description, Business Overview and Total Revenue
    • 11.2.3 Sanofi Winthrop Industrie S.A. Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Products Offered
    • 11.2.5 Sanofi Winthrop Industrie S.A. Recent Development
  • 11.3 Shandong Jiulong Fine Chemical Co., Ltd.
    • 11.3.1 Shandong Jiulong Fine Chemical Co., Ltd. Corporation Information
    • 11.3.2 Shandong Jiulong Fine Chemical Co., Ltd. Description, Business Overview and Total Revenue
    • 11.3.3 Shandong Jiulong Fine Chemical Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Products Offered
    • 11.3.5 Shandong Jiulong Fine Chemical Co., Ltd. Recent Development
  • 11.4 Hipharma Limited
    • 11.4.1 Hipharma Limited Corporation Information
    • 11.4.2 Hipharma Limited Description, Business Overview and Total Revenue
    • 11.4.3 Hipharma Limited Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Products Offered
    • 11.4.5 Hipharma Limited Recent Development
  • 11.5 AMPAC Fine Chemicals
    • 11.5.1 AMPAC Fine Chemicals Corporation Information
    • 11.5.2 AMPAC Fine Chemicals Description, Business Overview and Total Revenue
    • 11.5.3 AMPAC Fine Chemicals Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Products Offered
    • 11.5.5 AMPAC Fine Chemicals Recent Development
  • 11.6 BASF
    • 11.6.1 BASF Corporation Information
    • 11.6.2 BASF Description, Business Overview and Total Revenue
    • 11.6.3 BASF Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 BASF API(Active Pharmaceutical Ingredient) Intermediate Products Offered
    • 11.6.5 BASF Recent Development
  • 11.7 Cambrex Corporation
    • 11.7.1 Cambrex Corporation Corporation Information
    • 11.7.2 Cambrex Corporation Description, Business Overview and Total Revenue
    • 11.7.3 Cambrex Corporation Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Products Offered
    • 11.7.5 Cambrex Corporation Recent Development
  • 11.8 A R Life Sciences Pvt. Ltd.
    • 11.8.1 A R Life Sciences Pvt. Ltd. Corporation Information
    • 11.8.2 A R Life Sciences Pvt. Ltd. Description, Business Overview and Total Revenue
    • 11.8.3 A R Life Sciences Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Products Offered
    • 11.8.5 A R Life Sciences Pvt. Ltd. Recent Development
  • 11.9 Dragon Hwa ChemPharm. Co., Ltd.
    • 11.9.1 Dragon Hwa ChemPharm. Co., Ltd. Corporation Information
    • 11.9.2 Dragon Hwa ChemPharm. Co., Ltd. Description, Business Overview and Total Revenue
    • 11.9.3 Dragon Hwa ChemPharm. Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Products Offered
    • 11.9.5 Dragon Hwa ChemPharm. Co., Ltd. Recent Development
  • 11.10 Ami Life Sciences Pvt. Ltd.
    • 11.10.1 Ami Life Sciences Pvt. Ltd. Corporation Information
    • 11.10.2 Ami Life Sciences Pvt. Ltd. Description, Business Overview and Total Revenue
    • 11.10.3 Ami Life Sciences Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Products Offered
    • 11.10.5 Ami Life Sciences Pvt. Ltd. Recent Development
  • 11.1 Jigs Chemical
    • 11.1.1 Jigs Chemical Corporation Information
    • 11.1.2 Jigs Chemical Description, Business Overview and Total Revenue
    • 11.1.3 Jigs Chemical Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Products Offered
    • 11.1.5 Jigs Chemical Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 API(Active Pharmaceutical Ingredient) Intermediate Market Estimates and Projections by Region
    • 12.1.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Forecast by Regions 2021-2026
    • 12.1.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast by Regions 2021-2026
  • 12.2 North America API(Active Pharmaceutical Ingredient) Intermediate Market Size Forecast (2021-2026)
    • 12.2.1 North America: API(Active Pharmaceutical Ingredient) Intermediate Sales Forecast (2021-2026)
    • 12.2.2 North America: API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast (2021-2026)
    • 12.2.3 North America: API(Active Pharmaceutical Ingredient) Intermediate Market Size Forecast by Country (2021-2026)
  • 12.3 Europe API(Active Pharmaceutical Ingredient) Intermediate Market Size Forecast (2021-2026)
    • 12.3.1 Europe: API(Active Pharmaceutical Ingredient) Intermediate Sales Forecast (2021-2026)
    • 12.3.2 Europe: API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast (2021-2026)
    • 12.3.3 Europe: API(Active Pharmaceutical Ingredient) Intermediate Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: API(Active Pharmaceutical Ingredient) Intermediate Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: API(Active Pharmaceutical Ingredient) Intermediate Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America API(Active Pharmaceutical Ingredient) Intermediate Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: API(Active Pharmaceutical Ingredient) Intermediate Sales Forecast (2021-2026)
    • 12.5.2 Latin America: API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: API(Active Pharmaceutical Ingredient) Intermediate Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: API(Active Pharmaceutical Ingredient) Intermediate Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: API(Active Pharmaceutical Ingredient) Intermediate Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key API(Active Pharmaceutical Ingredient) Intermediate Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 API(Active Pharmaceutical Ingredient) Intermediate Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    API(Active Pharmaceutical Ingredient) Intermediate market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global API(Active Pharmaceutical Ingredient) Intermediate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the API(Active Pharmaceutical Ingredient) Intermediate market is segmented into
    By Product
    By Type of Intermediate

    Segment by Application, the API(Active Pharmaceutical Ingredient) Intermediate market is segmented into
    Oncology
    Diabetes
    Endocrinology
    Cardiovascular Disease
    CNS & Neurological Disorders

    Regional and Country-level Analysis
    The API(Active Pharmaceutical Ingredient) Intermediate market is analysed and market size information is provided by regions (countries).
    The key regions covered in the API(Active Pharmaceutical Ingredient) Intermediate market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and API(Active Pharmaceutical Ingredient) Intermediate Market Share Analysis
    API(Active Pharmaceutical Ingredient) Intermediate market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in API(Active Pharmaceutical Ingredient) Intermediate business, the date to enter into the API(Active Pharmaceutical Ingredient) Intermediate market, API(Active Pharmaceutical Ingredient) Intermediate product introduction, recent developments, etc.
    The major vendors covered:
    Jigs Chemical
    Sanofi Winthrop Industrie S.A.
    Shandong Jiulong Fine Chemical Co., Ltd.
    Hipharma Limited
    AMPAC Fine Chemicals
    BASF
    Cambrex Corporation
    A R Life Sciences Pvt. Ltd.
    Dragon Hwa ChemPharm. Co., Ltd.
    Ami Life Sciences Pvt. Ltd.


    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global API(Active Pharmaceutical Ingredient) Intermediate. Industry analysis & Market Report on COVID-19 Impact on Global API(Active Pharmaceutical Ingredient) Intermediate is a syndicated market report, published as COVID-19 Impact on Global API(Active Pharmaceutical Ingredient) Intermediate, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global API(Active Pharmaceutical Ingredient) Intermediate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,034.00
    4,551.00
    6,067.99
    3,309.40
    4,964.09
    6,618.79
    407,191.20
    610,786.80
    814,382.40
    286,915.20
    430,372.80
    573,830.40
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report